The effects of low molecular weight heparin [enoxaparin sodium] and aspirin therapy on recurrent pregnancy loss

Trial Profile

The effects of low molecular weight heparin [enoxaparin sodium] and aspirin therapy on recurrent pregnancy loss

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Aspirin; Enoxaparin sodium
  • Indications Embolism and thrombosis; Pregnancy; Spontaneous abortion
  • Focus Therapeutic Use
  • Acronyms SPIN
  • Most Recent Events

    • 31 May 2012 Additional lead trial centres added as reported by United Kingdom Clinical Research Network record.
    • 30 Jul 2010 Additional trial centres identified as reported by United Kingdom Clinical Research Network record.
    • 30 Jul 2010 New source identified and integrated (United Kingdom Clinical Research Network).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top